18 october 2022
Press releases
13 october 2022
News
The five key steps of the Quality by Design systematic approach for drug development
07 october 2022
News
EMA Gives Extra Time to Marketing Authorization Holders to Manage Nitrosamine Risk
30 august 2022
Newsletter
August 2022 Monthly Newsletter
19 july 2022
News
Brazil – Shorter Timelines for CTA (Clinical Trial Applications) Assessment
11 july 2022
News
Navigating the EAEU legislative changes for Medicinal Products
05 july 2022
News
PLG as Interim Marketing Authorisation Holder
29 june 2022
Newsletter
June 2022 Monthly Newsletter
22 june 2022
Press releases